Anteo Diagnostics Ltd has released a press release.
Managing Director AGM Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- European RAT Clinical Trial Halted to Refocus Initiatives
- FY22 Results Announcement
- Appendix 4E Preliminary Final Report
- CEO Appointment
- AnteoX Performance Validated by Two Global Battery Companies
Later from AnteoTech
- AnteoTech receives $3.2m R&D Tax Incentive
- Response to ASX Query
- Appendix 4D and Interim Financial Report
- AnteoTech signs MOU with Trinseo
- AnteoTech signs Non-Binding MOU with Wyon
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech